Clinical performance and cost-effectiveness of a Silicone foam with 3DFit™ technology in chronic wounds compared with standard of care: An open randomised multicentre investigation

A multi-centre study1 comparing the clinical performance and cost-effectiveness of Biatain® Silicone to the current Standard of Care – an Aquacel® Extra filler combined with a Mepilex® Border secondary dressing – showed that the Biatain Silicone was equally effective2, while being significantly more cost-efficient3, than the two-dressing regime over a four-week study period.

View the full article

Significant cost reduction when using Biatain Silicone

Using Biatain Silicone resulted in significant cost reduction of 33%3 (p-value=0.033) compared to the Standard of Care. Furthermore, the mean number of products was significantly lower for participants applying Biatain Silicone (5.6 products vs 10.6 for the Standard of Care), corresponding to a 47% reduction in products used. 


The HCP evaluated Biatain Silicone conformability to the wound bed and found that it was as effective as the two-dressing regime, a finding which further demonstrates the cost-savings potential of a single dressing regime.

Same clinical effectiveness at a lower cost

The results show that Biatain Silicone’s clinical performance was just as effective as the two-dressing regime. This simplified one-dressing treatment regime reduces costs, as it requires fewer products per patient and frees up time and costs associated with dressing changes. This benefits patients, healthcare providers and the environment.

<h2>Biatain® Silicone Square</h2>

Biatain® Silicone Square

<h2>Biatain Silicone Multishape</h2>

Biatain Silicone Multishape

<h2>Biatain Silicone Heel</h2>

Biatain Silicone Heel

<h2>Biatain Silicone Sacral Small</h2>

Biatain Silicone Sacral Small